Order Article Reprints

Fujii-Hanamoto A, Tanaka H, Fujimoto K, Haeno T, Miyake Y, Fujiwara R, Kumode T, Serizawa K, Morita Y, Hanamoto H, et al. Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells. Current Issues in Molecular Biology. 2025; 47(10):797. https://doi.org/10.3390/cimb47100797

Fujii-Hanamoto, Aki, Hirokazu Tanaka, Ko Fujimoto, Takahiro Haeno, Yoshiaki Miyake, Ryosuke Fujiwara, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, Hitoshi Hanamoto, and et al. 2025. "Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells" Current Issues in Molecular Biology 47, no. 10: 797. https://doi.org/10.3390/cimb47100797

Fujii-Hanamoto, A., Tanaka, H., Fujimoto, K., Haeno, T., Miyake, Y., Fujiwara, R., Kumode, T., Serizawa, K., Morita, Y., Hanamoto, H., Rai, S., & Matsumura, I. (2025). Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells. Current Issues in Molecular Biology, 47(10), 797. https://doi.org/10.3390/cimb47100797